Lilly's weight loss drug approved in China

Lilly weight-loss drug copycats dealt blow

Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says

The FDA declared the end to shortages of Zepbound and Mounjaro. That could mean new restrictions on pharmacies making custom-made versions.

Fast Company · 15h

Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over

The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 medications.

Detroit News · 21h

Lilly weight-loss drug copycats dealt blow as shortage ends

Eli Lilly and Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the US, threatening to upend the many knockoffs.

16h

Eli Lilly’s weight-loss drug no longer in shortage, FDA says

The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug ...

The Motley Fool28d

This Big Move by Eli Lilly May Solve the Weight Loss Drug Market's Biggest Problem

Eli Lilly's weight loss drugs are bringing in billions of ... This represents lost revenue for makers of the approved drugs. Lilly's recent moves have made big steps in addressing the ...

China cracks down on illegal copies of Novo’s obesity drug

China has started cracking down on unlicensed production and sale of medicines similar to Novo Nordisk A/S’s blockbuster ...

NBC 10 Philadelphia22d

Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs

Eli Lilly will invest $1.8 billion to boost manufacturing for its newly approved Alzheimer's drug and highly popular weight loss and diabetes treatments, among other medicines, in Ireland.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending on Bing